Home EIPG Newsletter Technology & Production A new Strategic Agenda for cell-based interceptive medicine
A new Strategic Agenda for cell-based interceptive medicine
The LifeTime Initiative has launched its ten years roadmap for research in the new area of cell-based interceptive medicine. The ambitious goal is to precisely map the trajectory of diseases in five main therapeutic areas up to the single cell level, in order to select the best available treatment for each patient
